PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma

NCT05743777 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Company withdrew financial support

Conditions

Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Pembrolizumab
DRUG: MET-4
DRUG: Placebo

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]